Proefferocytic Therapy Promotes Transforming Growth Factor-β Signaling and Prevents Aneurysm Formation

Circulation. 2018 Feb 13;137(7):750-753. doi: 10.1161/CIRCULATIONAHA.117.030389.

¹ Department of Surgery, Division of Vascular Surgery (Y.K., N.W., J.Y., V.N., N.T., Y.W., A.M.F., H.D., B.X., R.L.D., N.J.L.).
² Department of Medicine, Division of Cardiovascular Medicine (C.L.M., N.J.L.).
³ Institute for Stem Cell Biology and Regenerative Medicine (I.W.).
⁴ Stanford University School of Medicine, CA. Department of Medicine, Karolinska Institute, Stockholm, Sweden (S.M.E., L.M.).
⁵ Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University Munich and German Center for Cardiovascular Research Partner Site Munich, Munich, Germany (J.P., Y.L., L.M.).
⁶ Department of Surgery, Division of Vascular Surgery (Y.K., N.W., J.Y., V.N., N.T., Y.W., A.M.F., H.D., B.X., R.L.D., N.J.L.) nleeper@stanford.edu.

No abstract available

Keywords: TGFβ; aneurysm; efferocytosis; macrophage; phagocytosis; vascular biology.

Publication types